Viewing Study NCT01880567


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:46 PM
Study NCT ID: NCT01880567
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2013-06-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module